Exhibit 32(b)


            CERTIFICATION OF CHIEF FINANCIAL OFFICER
               PURSUANT TO 18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In  connection  with  the  IGENE  Biotechnology,  Inc.  (the
"Company")  Quarterly Report on Form 10-QSB for the period  ended
September  30,  2004, as filed with the Securities  and  Exchange
Commission  on  the  date  hereof (the "Report"),  I,  Edward  J.
Weisberger,  Chief  Financial Officer  of  the  Company,  certify
pursuant  to  18  U.S.C.  Section 1350, as  adopted  pursuant  to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to the  best
of my knowledge:

     (1). The  Report  fully  complies  with  the requirements of
          Section  13(a)  or 15(d) of the Securities Exchange Act
          of 1934, as amended; and

     (2). The  information   contained  in  the   Report   fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Company.


Date: November 11, 2004          By:  /s/EDWARD J. WEISBERGER
                                      ___________________________
                                         EDWARD J. WEISBERGER
                                         Chief Financial Officer




A  signed  original of this written statement required by Section
906  has been provided to the Company and will be retained by the
Company  and  furnished to the Securities and Exchange Commission
or its staff upon request.